- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02016404
The Effect of a Low Sodium-High Potassium Salt on Blood Pressure in Vietnamese Adults
December 13, 2013 updated by: Wageningen University
The purpose of this study was to investigate the effects of low-sodium, high-potassium condiments and salt on blood pressure in untreated (pre)hypertensive Vietnamese adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hai Ba Trung dist.
-
Hanoi, Hai Ba Trung dist., Vietnam
- National Institute of Nutrition (NIN), Department of Community Nutrition
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 64 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Untreated prehypertension or mild hypertension (systolic BP between 130 and 160 mmHg and/or diastolic BP between 85 and 100 mmHg) based on the mean of two measurements with a 1-week interval
Exclusion Criteria:
Diagnosed or self-reported cardiovascular disease Diagnosed or self-reported kidney disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Low-sodium, high-potassium salt
Iodized low-sodium, high-potassium botcanh (a traditional mixture of salt, mono sodium glutamate (MSG), sugar and herbs) plus and iodized low-sodium, high-potassium salt for home food preparation
|
Iodized low-sodium, high-potassium botcanh (a traditional mixture of salt, MSG, sugar and herbs) plus and iodized low-sodium, high-potassium salt for home food preparation
|
|
Placebo Comparator: Regular salt
Regular iodized high-sodium botcanh (a traditional mixture of salt, MSG, sugar and herbs) and high-sodium salt
|
Regular iodized high-sodium botcanh (a traditional mixture of salt, MSG, sugar and herbs) and high-sodium salt
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in office systolic blood pressure (SBP)
Time Frame: Change during 8 weeks of intervention
|
Based on repeated measurements with a digital BP device (OMRONHEM 762) using the standard protocol of WHO STEP guideline at week 0, 2, 4 6 and 8.
|
Change during 8 weeks of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in office diastolic blood pressure (DBP)
Time Frame: Change during 8 weeks of intervention
|
Based on repeated measurements with a digital BP device (OMRONHEM 762) using the standard protocol of WHO STEP guideline at week 0, 2, 4, 6 and 8.
|
Change during 8 weeks of intervention
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in 24-hour urinary sodium excretion
Time Frame: Change during 8 weeks of intervention
|
Change during 8 weeks of intervention
|
|
Change in 24-hour urinary potassium excretion
Time Frame: Change during 8 weeks of intervention
|
Change during 8 weeks of intervention
|
|
Change in body weight
Time Frame: Change during 8 weeks of intervention
|
Change during 8 weeks of intervention
|
|
Change in 24-hour urinary calcium excretion
Time Frame: Change during 8 weeks of intervention
|
Change during 8 weeks of intervention
|
|
Change in 24-hour urinary iodine excretion
Time Frame: Change during 8 weeks of intervention
|
Change during 8 weeks of intervention
|
|
Change in 24-hour urinary creatinine excretion
Time Frame: Change during 8 weeks of intervention
|
Change during 8 weeks of intervention
|
|
Change in 24-hour urinary protein
Time Frame: Change during 8 weeks of intervention
|
Change during 8 weeks of intervention
|
|
Change in heart rate
Time Frame: Change during 8 weeks of intervention
|
Change during 8 weeks of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ha TP Do, Community Nutrition, National Institute of Nutrition, Vietnam
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
December 9, 2013
First Submitted That Met QC Criteria
December 13, 2013
First Posted (Estimate)
December 20, 2013
Study Record Updates
Last Update Posted (Estimate)
December 20, 2013
Last Update Submitted That Met QC Criteria
December 13, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0793
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Low-sodium, high-potassium salt
-
The George InstituteUniversity of Auckland, New Zealand; James Cook University, Queensland, Australia and other collaboratorsCompleted
-
University of DelawareNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Risk FactorUnited States
-
University of DelawareCompleted
-
University Hospital, GenevaCompleted
-
University of Southern DenmarkOdense University Hospital; Beckett Foundation; Danish Diabetes AcademyCompleted
-
DongGuk UniversityMinistry of Food and Drug Safety, KoreaUnknownHypertension | PrehypertensionKorea, Republic of
-
Vanderbilt UniversityCompleted
-
The George InstituteUniversity of Abuja Teaching HospitalCompletedBlood PressureNigeria
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Aga Khan UniversityWellcome TrustUnknown